Crescioli Silvia, Correa Isabel, Karagiannis Panagiotis, Davies Anna M, Sutton Brian J, Nestle Frank O, Karagiannis Sophia N
St. John's Institute of Dermatology, Division of Genetics and Molecular Medicine; Faculty of Life Sciences and Medicine, King's College London, London, UK.
NIHR Biomedical Research Centre at Guy's and St. Thomas's Hospitals and King's College London, King's College London, London, UK.
Curr Allergy Asthma Rep. 2016 Jan;16(1):7. doi: 10.1007/s11882-015-0580-7.
IgG4 is the least abundant subclass of IgG in normal human serum, but elevated IgG4 levels are triggered in response to a chronic antigenic stimulus and inflammation. Since the immune system is exposed to tumor-associated antigens over a relatively long period of time, and tumors notoriously promote inflammation, it is unsurprising that IgG4 has been implicated in certain tumor types. Despite differing from other IgG subclasses by only a few amino acids, IgG4 possesses unique structural characteristics that may be responsible for its poor effector function potency and immunomodulatory properties. We describe the unique attributes of IgG4 that may be responsible for these regulatory functions, particularly in the cancer context. We discuss the inflammatory conditions in tumors that support IgG4, the emerging and proposed mechanisms by which IgG4 may contribute to tumor-associated escape from immune surveillance and implications for cancer immunotherapy.
IgG4是正常人血清中含量最少的IgG亚类,但在慢性抗原刺激和炎症反应中,IgG4水平会升高。由于免疫系统在相对较长的时间内接触肿瘤相关抗原,且肿瘤会显著促进炎症反应,因此IgG4与某些肿瘤类型有关也就不足为奇了。尽管IgG4与其他IgG亚类仅相差几个氨基酸,但其具有独特的结构特征,这可能是其效应功能较弱和免疫调节特性的原因。我们描述了可能导致这些调节功能的IgG4的独特属性,特别是在癌症背景下。我们讨论了支持IgG4的肿瘤炎症情况、IgG4可能导致肿瘤相关免疫逃逸的新出现和提出的机制,以及对癌症免疫治疗的影响。